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Background: Emerging evidence suggests that women at risk of hereditary breast cancer who 
remain ineligible for predictive testing experience elevated distress compared with tested women, 
while individuals who have declined or delayed learning their result report less distress than tested 
individuals.   
 
Method: This study compared women who opt for, delay, decline or remain ineligible for predictive 
testing with regard to cancer-related distress (CRD; Impact of Events Scale), anxiety and depression 
(Hospital Anxiety and Depression Scale) in 1131 unaffected women enrolled in the Kathleen 
Cuningham Consortium for Research into Familial breast cancer (kConFab) psychosocial study, 
controlling for stressful life events (Life Event and Difficulties Schedule) and perceived risk of breast 
cancer. Controlling for potential confounders (age, education, perceived risk and cumulative life event 
stress), statistical significance and clinical relevance of differences between 120 testers (pre-
notification of eligibility for testing), 56 decliners, 90 delayers and 865 women who were ineligible for 
testing (ineligibles) were investigated. 
 
Results: Delayers and testers reported significantly higher CRD compared with decliners (95%CIs 
1.543 - 5.796, 2.795 - 6.870, respectively; ps≤.001) and ineligibles (95%CIs 0.066 - 2.891, 1.411 - 
3.872, respectively; ps<.05). Moderate-high CRD was observed in 14% of decliners, 24% of 
ineligibles, 34% of delayers and 42% of testers (χ2=24.73, p<.001). Decliners reported less anxiety 
than delayers (-3.169 - -0.567, p=.005) and testers (-2.858 - -.365, p=.011) with possible/definite 
anxiety disorder in 25% of decliners, 34% of ineligibles, 53% of delayers and 44% of testers 
(χ2=19.21, p<.001). No clinically significant differences in depression were observed and prevalence 
of depression did not differ between groups (χ2=3.49, p=.322). 
 
Conclusion: Decliners and delayers have distinctly different distress profiles and should be 
considered as separate groups. Delayers report significantly higher levels of distress, similar to those 
who opt for testing, indicating that these two groups have the greatest need for psychological support 
and would benefit most from supportive interventions. 
 
 
 
